These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5983123)

  • 1. [On the comparative efficacy of desferrioxamine and DTPA as agents for the elimination of plutonium in poisoned rats].
    Truhaut R; Boudène C; Lutz M; Métivier H
    Arch Mal Prof; 1966 Sep; 27(9):669-76. PubMed ID: 5983123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined reticuloendothelial stimulation and long-term, intermittent DTPA therapy in poisoning by polymeric plutonium. ANL-7409.
    Rosenthal MW; Smoler HM; Lindenbaum A
    ANL Rep; 1967; ():180. PubMed ID: 5308231
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
    Stradling GN; Gray SA; Moody JC; Hodgson A; Raymond KN; Durbin PW; Rodgers SJ; White DL; Turowski PN
    Int J Radiat Biol; 1991 May; 59(5):1269-77. PubMed ID: 1675243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of standard Licam (C) in plutonium radiocontamination].
    Gerasimo P; Duserre C; Ducousso R; Metivier H
    Ann Pharm Fr; 1987; 45(3):189-94. PubMed ID: 3434970
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
    Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
    ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
    [No Abstract]   [Full Text] [Related]  

  • 8. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed ligand chelates and plutonium poisoning.
    Humphreys ER; Stones VA
    Health Phys; 1980 Jul; 39(1):103-5. PubMed ID: 7419398
    [No Abstract]   [Full Text] [Related]  

  • 10. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of early DTPA treatments in two types of plutonium exposures in humans.
    Lagerquist CR; Hammond SE; Putzier EA; Piltingsrud CW
    Health Phys; 1965 Nov; 11(11):1177-80. PubMed ID: 5867870
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
    Kazzi ZN; Heyl A; Ruprecht J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro chelation of plutonium by alpha-lipoic acid and DTPA. BNWL-714.
    Dilley JV
    BNWL Rep; 1968 May; ():6.12-6+. PubMed ID: 4898101
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products.
    Métvier H; Masse R; Nolibé D; Nénot JC; Lafuma J
    Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides.
    Lushbaugh CC; Washburn LC
    J Nucl Med; 1979 Jan; 20(1):73. PubMed ID: 219167
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of Zn-DTPA in removing plutonium from the human body.
    Ohlenschläger L
    Health Phys; 1976 Feb; 30(2):249-50. PubMed ID: 1245431
    [No Abstract]   [Full Text] [Related]  

  • 18. Decorporation of 239Pu and 241Am in the rat and hamster by Zn-DTPA.
    Volf V; Seidel A
    Radiat Res; 1974 Sep; 59(3):638-44. PubMed ID: 4428011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
    Rahman YE; Rosenthal MW; Cerny EA
    Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.